BioCryst Pharmaceuticals Inc (BCRX)
4.47
-0.10
(-2.19%)
USD |
NASDAQ |
May 02, 16:00
4.47
0.00 (0.00%)
After-Hours: 18:51
BioCryst Pharmaceuticals Cash from Operations (Quarterly): -8.918M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.918M |
| September 30, 2023 | -19.90M |
| June 30, 2023 | -18.81M |
| March 31, 2023 | -47.51M |
| December 31, 2022 | -23.85M |
| September 30, 2022 | -32.44M |
| June 30, 2022 | -27.76M |
| March 31, 2022 | -77.80M |
| December 31, 2021 | -32.46M |
| September 30, 2021 | -23.28M |
| June 30, 2021 | -25.41M |
| March 31, 2021 | -61.01M |
| December 31, 2020 | -42.53M |
| September 30, 2020 | -38.26M |
| June 30, 2020 | -31.04M |
| March 31, 2020 | -23.28M |
| December 31, 2019 | -10.45M |
| September 30, 2019 | -27.64M |
| June 30, 2019 | -24.50M |
| March 31, 2019 | -27.00M |
| December 31, 2018 | -23.98M |
| September 30, 2018 | -35.03M |
| June 30, 2018 | -13.90M |
| March 31, 2018 | -19.65M |
| December 31, 2017 | -10.52M |
| Date | Value |
|---|---|
| September 30, 2017 | -12.43M |
| June 30, 2017 | -9.667M |
| March 31, 2017 | -8.527M |
| December 31, 2016 | -5.854M |
| September 30, 2016 | -17.56M |
| June 30, 2016 | -11.18M |
| March 31, 2016 | -18.84M |
| December 31, 2015 | -14.83M |
| September 30, 2015 | -12.66M |
| June 30, 2015 | 18.10M |
| March 31, 2015 | -3.726M |
| December 31, 2014 | -13.89M |
| September 30, 2014 | -8.60M |
| June 30, 2014 | -7.102M |
| March 31, 2014 | -8.959M |
| December 31, 2013 | -4.515M |
| September 30, 2013 | -7.922M |
| June 30, 2013 | -2.895M |
| March 31, 2013 | -11.20M |
| December 31, 2012 | -7.03M |
| September 30, 2012 | -11.78M |
| June 30, 2012 | -6.342M |
| March 31, 2012 | -12.25M |
| December 31, 2011 | -3.984M |
| September 30, 2011 | -10.47M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-77.80M
Minimum
Mar 2022
-8.918M
Maximum
Dec 2023
-31.41M
Average
-27.64M
Median
Sep 2019
Cash from Operations (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 3.595M |
| Electromed Inc | 3.471M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -28.47M |
| Cash from Financing (Quarterly) | -3.173M |
| Free Cash Flow | -97.31M |
| Free Cash Flow Per Share (Quarterly) | -0.047 |
| Free Cash Flow to Equity (Quarterly) | 12.44M |
| Free Cash Flow to Firm (Quarterly) | 10.19M |
| Free Cash Flow Yield | -11.33% |